According to records kept by The Financial Industry Regulatory Authority (FINRA) financial Broker Bryan Emerson (Emerson), currently associated with Cim Securities, LLC, has at least one disclosable event. These events include one customer complaint, alleging that Emerson recommended unsuitable investments in different investment products including debt securities among other allegations and complaints.
FINRA BrokerCheck shows a pending customer complaint on February 24, 2026.
Summary of FINRA Arbitration (FINRA Case No. 25-02386) and Bryan Emerson’s Involvement\, \, This matter is a FINRA customer arbitration brought by multiple individual claimants against Sequence Financial Specialists LLC (‘Sequence’) and, by amendment, certain associated individuals, including Bryan Emerson. \, \, Nature of the Case\, The claim arises from the recommendation and sale of syndicated conservation easement (‘SCE’) investments, which were marketed as tax-advantaged strategies offering significant deductions and environmental benefits. Claimants allege that Sequence and its representatives misrepresented the legitimacy, risk profile, and IRS compliance of these investments, assuring investors they would withstand scrutiny. \, \, According to the Statement of Claim, the investments were in fact unsuitable and improperly vetted. The IRS later designated such transactions as ‘listed transactions’ and challenged the associated tax deductions, resulting in audits, disallowed deductions, back taxes, penalties, and interest for the claimants. \, \, The claimants assert that Sequence failed to conduct adequate due diligence and violated FINRA obligations regarding reasonable-basis and customer-specific suitability, as well as supervisory requirements for alternative investments. \, \, Claims Asserted\, The arbitration includes multiple causes of action, including:\, \, * Unsuitability\, * Common law fraud\, * Breach of contract\, * Negligent supervision\, * Breach of fiduciary duty\, * Negligence\, * Control person liability\, \, Claimants seek compensatory damages, interest, attorneys’ fees, and other relief based on losses and liabilities arising from IRS actions and the alleged misconduct. \, \, Bryan Emerson’s Role as Defendant\, Bryan Emerson was added as an individual respondent through a Motion to Amend, alongside other senior personnel, on the basis that he was a ‘control person’ of Sequence. \, \, The claimants allege that Emerson:\, \, * Held supervisory and/or principal responsibilities at Sequence during the relevant period\, * Was involved in, or had responsibility for, the due diligence, approval, and supervision of the SCE investments\, * Exercised control over the firm and its registered representatives\, * Owed an independent duty to ensure compliance with securities laws and FINRA rules\, \, The claim further asserts that, as a control person, Emerson May be jointly and severally liable for the firm’s alleged misconduct, including failures in supervision and compliance systems. \, \, Importantly, Emerson is not alleged to have directly sold the investments to claimants, but rather is named in a supervisory and control capacity, with liability premised on alleged failures in oversight, due diligence, and compliance infrastructure. Emerson disputes all of these claims.\, \, Procedural Context\, The amendment adding Emerson and other individuals was justified by claimants on the grounds that Sequence May lack sufficient assets or insurance to satisfy a potential award, making recovery from control persons necessary.
Securities Lawyers Blog
